Candel Therapeutics (CADL) Shares Outstanding (Diluted Average) (2021 - 2023)
Historic Shares Outstanding (Diluted Average) for Candel Therapeutics (CADL) over the last 3 years, with Q3 2023 value amounting to $28.9 million.
- Candel Therapeutics' Shares Outstanding (Diluted Average) rose 9.66% to $28.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 9.66%. This contributed to the annual value of $28.8 million for FY2022, which is 5272.3% up from last year.
- According to the latest figures from Q3 2023, Candel Therapeutics' Shares Outstanding (Diluted Average) is $28.9 million, which was up 9.66% from $28.9 million recorded in Q2 2023.
- In the past 5 years, Candel Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $28.9 million in Q1 2023 and a low of $11.7 million during Q2 2021
- Over the past 3 years, Candel Therapeutics' median Shares Outstanding (Diluted Average) value was $28.8 million (recorded in 2022), while the average stood at $25.6 million.
- Per our database at Business Quant, Candel Therapeutics' Shares Outstanding (Diluted Average) soared by 14580.99% in 2022 and then increased by 9.66% in 2023.
- Over the past 3 years, Candel Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $18.9 million in 2021, then skyrocketed by 52.72% to $28.8 million in 2022, then rose by 0.33% to $28.9 million in 2023.
- Its last three reported values are $28.9 million in Q3 2023, $28.9 million for Q2 2023, and $28.9 million during Q1 2023.